Coagulant Therapeutics Corporation

Initiated from assets licensed from Bayer AG, Coagulant is leveraging both its Coagulation Cascade and Biologics expertise to develop a portfolio of drugs for the treatment of acute bleeding and adjacent indications including sepsis.

Address

Visit website (opens in a new tab)
Loading